Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart

Charlotte Gredal, Anne Mette Rosenfalck, Anders Dejgaard, Jannik Hilsted

    3 Citations (Scopus)

    Abstract

    To assess the effect of substitution of early insulin release with a small weight-based dose of the rapid acting insulin analogue, insulin Aspart (IAsp), on postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes.
    Original languageEnglish
    JournalScandinavian Journal of Clinical & Laboratory Investigation
    Volume68
    Issue number8
    Pages (from-to)739-44
    Number of pages6
    ISSN0036-5513
    DOIs
    Publication statusPublished - 2008

    Keywords

    • Blood Glucose
    • Body Weight
    • Diabetes Mellitus, Type 2
    • Dose-Response Relationship, Drug
    • Drug Administration Schedule
    • Female
    • Humans
    • Hyperglycemia
    • Injections, Subcutaneous
    • Insulin
    • Insulin Aspart
    • Male
    • Middle Aged
    • Placebos

    Fingerprint

    Dive into the research topics of 'Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart'. Together they form a unique fingerprint.

    Cite this